Green Thumb Industries (GTBIF) Gains from Investment Securities (2020 - 2026)
Green Thumb Industries' (GTBIF) quarterly Gains from Investment Securities came in at $1.1 million in Q1 2026, up 53.49% on a QoQ basis from $731000.0 in Q1 2023.
Green Thumb Industries (GTBIF) Gains from Investment Securities (2020 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 5 years of Gains from Investment Securities data on file, last reported at $1.1 million in Q1 2026.
- Quarterly Gains from Investment Securities changed N/A year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.6 million (up 25.18% YoY) and the FY2025 annual result came in at -$125.9 million, changed N/A from the prior year.
- Gains from Investment Securities climbed to $1.1 million in Q1 2026, from $731000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $2.8 million in Q4 2022 to a low of -$16.6 million in Q2 2022.
- A 3-year average of -$4.5 million and a median of $461000.0 in 2022 frame the typical range for Gains from Investment Securities.
- The widest YoY moves for Gains from Investment Securities: up 131.06% in 2022, down 3827.85% in 2022.
- Tracing GTBIF's Gains from Investment Securities over 3 years: stood at $2.8 million in 2022, then plunged by 73.66% to $731000.0 in 2023, then soared by 53.49% to $1.1 million in 2026.
- The last three Gains from Investment Securities figures came in at $1.1 million (Q1 2026), $731000.0 (Q1 2023), and $2.8 million (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Green Thumb Industries | 1.65 Bn | 1.37 Bn | 137.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.12 Mn |
| Mar 31, 2026 | 1.12 Mn |
| Mar 31, 2023 | 731,000.00 |
| Mar 31, 2023 | 731,000.00 |
| Dec 31, 2022 | 2.78 Mn |
| Dec 31, 2022 | 2.78 Mn |
| Sep 30, 2022 | 191,000.00 |
| Sep 30, 2022 | 191,000.00 |
| Jun 30, 2022 | -16.58 Mn |
| Jun 30, 2022 | -16.58 Mn |
| Mar 31, 2022 | -15.40 Mn |
| Mar 31, 2022 | -15.40 Mn |
| Dec 31, 2021 | -8.94 Mn |
| Dec 31, 2021 | -8.94 Mn |
| Sep 30, 2021 | 249,000.00 |
| Sep 30, 2021 | 249,000.00 |
| Mar 31, 2021 | 413,000.00 |
| Mar 31, 2021 | 413,000.00 |
| Dec 31, 2020 | -8.22 Mn |
| Dec 31, 2020 | -8.22 Mn |